Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
British Journal of Clinical Pharmacology|January 12, 2013
Reduced indinavir exposure during pregnancyTim R Cressey, Brookie M Best, Jullapong Achalapong, et al.The Pediatric Infectious Disease Journal|March 6, 2015
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaImke H Bartelink, Rada M Savic, Grant Dorsey, et al.Antiviral Therapy|December 14, 2011
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit, Tim R Cressey, Edmund Capparelli, et al.The Pediatric Infectious Disease Journal|February 12, 2009
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacyEllen Gould Chadwick, Jorge Pinto, Ram Yogev, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2021
Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE StudyAdrie Bekker, Helena Rabie, Nicolas Salvadori, et al.Malaria Journal|May 10, 2011
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malariaCarrie A Morris, Marie A Onyamboko, Edmund Capparelli, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2015
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant WomenAngela Colbers, Brookie Best, Stein Schalkwijk, et al.The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.Clinical Pharmacokinetics|March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.Journal of Molecular Neuroscience : MN|June 13, 2002
A phase I study of AIT-082 in healthy elderly volunteersMichael Grundman, Martin Farlow, Guerry Peavy, et al.Pageof 9